SARS-CoV-2. Don’t let up. We’ll help.

Order by stock part number »
Get Help
 |  EN
Sign In
ProcessingProcessing
  1. Blog
  2. Enabling personalized biomarker discovery in challenging oncology research samples
Lab life

Enabling personalized biomarker discovery in challenging oncology research samples

Jul 28, 2020
Even though cost of sequencing has precipitously dropped, it is still a challenge to convert low quality and low quantity samples from cfDNA and FFPE into sequencable libraries. This workflow drives high conversion with challenging samples using a unique single stranded blunt ligation strategy (Prism) in combination with IDT’s hyb capture products.
Enabling personalized biomarker discovery in challenging oncology research samples hero image

The American Association for Cancer Research (AACR) annual meeting was shifted to a virtual session this year. Programs, presentations, papers, lectures, symposia, and sessions were held online, instead of in person. This included poster presentations, which were held in a virtual format for the first time.

IDT was proud to present a series of posters at #AACR20, including this one, titled: “Enabling Personalized Biomarker Discovery in Challenging Oncology Samples by Coupling a Novel Library Preparation Chemistry with Hybridization Capture.”

The poster is presented by IDT Research Scientist II Karissa Scott, and it should be of particular interest to researchers involved in biomarker discovery work, and researchers using low quality and low quantity samples from cfDNA and FFPE for NGS based assays.

Here is the AACR poster presentation:

Tags:

ngs hybrid capture FFPE